BiykemBozkurt

New brief report in @JACCJournals #JACCHF evaluating feasibility of withdrawing #GDMT and keeping pts w/ HFimpEF (EF <40 hx➡️ >50) just on carvedilol (50 mg/day) ✅ no sig difference in HF/EF at 52 weeks Opposing trial results vs. TRED-HF? 📎 jacc.org/doi/10.1016/j.…

At the #3CT #HFC members are leading the way in the session "Acute #HeartFailure: Ready for Personalized Post-Discharge?" @coconnormd (moderator) @BiykemB on devices & GDM @RandiRising on QOL > survival Plus @mpsotka @mrchrtfaildoc @FudimMara also presenting across key sessions

@BiykemB leading the way 👏🏼👏🏼👏🏼

Selfie with Prof.Dr.Lynne Warner Stevenson: The inspirer of my academic career in HF. #HeartFailure2025

HFA Eugene Braunwald Lecture by @WilfriedMullens - Lynne Warner Stevenson and her incredible contribution to HF Lead investigator 500+ publications Editorial board member 7 journals Contributor to 30+ HF guidelines Trained 70 HF fellows (50% women) #HeartFailure2025

So honored to have my mentor, Dr. Lynne Stevenson, receive the 2021 HFSA Lifetime Achievement Award. She has trained a generation of advanced HF specialists, including me. I will always be indebted to her for leading me to this wonderful career path.🙏

HFA Eugene Braunwald Lecture by Dr. Lynne Stevenson — celebrating her groundbreaking contributions and lasting impact on the world of heart failure. A true pioneer! #HeartFailure2025 @slumberbell @WilfriedMullens @AmrAbdin10 @escardio

Professor Dr Biykem Bozkurt was my mentor during the HFA Career Café event. It was a great honour for me to meet you. @BiykemB #HeartFailure2025

Finerenone Reduces New-Onset Atrial Fibrillation Across the Spectrum of Cardio-Kidney-Metabolic Syndrome: The FINE-HEART Pooled Analysis The nonsteroidal MRA finerenone reduced the risk of new-onset AF/AFL across the CKM spectrum jacc.org/doi/10.1016/j.…

Growth Hormone Replacement Therapy in HFREF : A Randomized, Double-Blind, Placebo-Controlled Trial GH replacement therapy in HFrEF patients with GHD improves exercise performance, and left ventricular and right ventricular structure and function jacc.org/doi/10.1016/j.…

Management of Heart Failure With Improved Ejection Fraction: Current Evidence and Controversies Partial de-escalation of GDMT might be safe in patients with low risk of relapse, although large trials are needed jacc.org/doi/10.1016/j.…

Finerenone Across the Spectrum of Kidney Risk in Heart Failure: FINEARTS-HF Trial Finerenone appears to consistently improve clinical outcomes, HF-related health status, and albuminuria across a broad spectrum of kidney risk in patients with HFmrEF/HFpEF jacc.org/doi/10.1016/j.…

Simultaneous publications from #FINEARTSHF w #ACC2025 in @JACCJournals & @JAMACardio 🔥 Reduction in New-Onset AF across CKM Spectrum 🔥 Effects on Mode of Death 🔥 Consistent Benefits across Functional Class, Kidney Risk & AF Subgroups Find out more 👇🏾 finearts-hf.org

Wow! 😳 P3 #ZENITH RCT stopped early for overwhelming efficacy Sotatercept, an activin signaling inhibitor already proven to slow progression in lower risk PAH, now shown to dramatically ⬇️ death or worsening in advanced PAH HR 0.24 (0.13-0.43) P<0.001 nejm.org/doi/full/10.10…

CADENCE is fully enrollled! We’ll have some answers soon! @mardigomberg @jeanlucvachiery

#ACC25 #JACCJournals @hmkyale @CandiceSilvers1 @BiykemB @PennThalheimer @GilbertTangMD @shivkumarmd

Practical & actionable guidance🫀✨ Great discussion about all the documents made for clinical guidance @NicoleBhaveMD @PanjrathG @BiykemB @MCoylewright @ShashankSinhaMD #ACC25 @ACCinTouch @Cardiology